Mental Health / Psychiatry
Peer-reviewed studies and reviews on Deep TMS for Depression.
Showing Depression · 37–54 of 95
The comparative efficacy of rTMS and dTMS is a topic of debate among practitioners. Data from real-world clinical settings can be informative. Objective: To compare rTMS and dTMS devices for the treatment of MDD. Methods: This study included two groups of patients with MDD. Group 1 included 45 patients (30%…
Electroconvulsive Therapy (ECT) is believed to be an effective treatment for treatment resistant depression (TRD). However, ECT has been associated with major side-effects including cognitive sequel. Alternatively, deep Transcranial Magnetic Stimulation (dTMS) is another effective treatment for alleviating MDD symptoms. Reports comparing efficacy…
Currently, pharmacotherapy is the first-line treatment for Major Depressive Disorder (MDD). However, review of clinical studies has revealed that 2/3 of MDD patients do not respond sufficiently to pharmacotherapy alone. This in turn, has a considerable impact on MDD patients’ overall wellbeing and Quality of Life (QOL).…
A positive correlation between caffeine consumption and depression was recently reported. Biologically, caffeine inhibits adenosine A1 and A2A receptors. Researchers link A2A receptors with depression pathogenesis. They suggest a tight interaction between A2A receptors and Trk-B receptors which are upstream of Brain-Derived Neurotrophic…
Deep Transcranial Magnetic Stimulation (dTMS) received FDA clearance in 2013 for the treatment of depression. As of yet, there are no post-marketing outcome data in “real world” practices. Objective: To examine a retrospective cohort of ten patients, ages 20-74, who received dTMS for treatment-resistant major depressive…
The efficacy of deep TMS (dTMS) in depression has been shown in clinical trials. However, few dTMS studies have been conducted in naturalistic settings. Objective: To review response rates to dTMS treatment in a real-world clinical practice setting. Methods: This study includes eight patients, ages 25 to 57…
Deep TMS (dTMS) clinical trials using H-coil technology in Major depressive disorder (MDD) patients has shown significant outcomes following standardized treatment protocols. However, in naturalistic settings physicians adapt treatment protocols to individual clinical considerations achieving better outcomes. These varied therapeutic strategies may inform other physicians…
Deep transcranial magnetic stimulation (dTMS) is an emerging and promising treatment for major depression. In our study, we explored the effectiveness of a second antidepressant course of dTMS in major depression. Objective: To evaluate whether a second course of dTMS would be effective. Methods: Eight depressive patients who relapsed…
Adolescent depression is a critical and growing public health concern, with high rates of treatment resistance and limited effective interventions. Deep Transcranial Magnetic Stimulation (Deep TMS) has been previously validated for adults, but data on its use in adolescents remain limited. Objective:To…
This systematic review aimed to evaluate and compare the safety and effectiveness of deep transcranial magnetic stimulation (dTMS) with high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) for individuals diagnosed with major depressive disorder (MDD). The study was motivated by the inconsistent findings of prior studies comparing dTMS and HF-rTMS for depression treatment. The…
Transcranial magnetic stimulation (TMS) is an intervention for treatment-resistant depression (TRD) that modulates neural activity. Deep TMS (dTMS) can target not only cortical but also deeper limbic structures implicated in depression. Although TMS has demonstrated safety in adolescents, dTMS has yet to…
Late-life depression (LLD) is a growing worldwide problem due to demographic changes, with limited treatment options due to high rates of pharmacotherapy adverse effects, accessibility of psychotherapy, and tolerability of electroconvulsive therapy. Novel neuromodulation techniques, such as repetitive transcranial magnetic stimulation (rTMS),…
Repetitive transcranial magnetic stimulation (rTMS) is an effective and well-established treatment for major depressive disorder (MDD). Deep TMS utilizes specially designed H-Coils to stimulate the deep and broad cerebral regions associated with the reward system. The improved depth penetration of Deep TMS…
Major Depressive Disorder (MDD) is a pervasive psychiatric condition effecting approximately 21 million adults in the U.S. (8.4%). An estimated 30–60% of patients are resistant to traditional treatment approaches (medications and talk-therapy), alluding to the need for additional options. Two promising treatment…
Evidence suggests that depressive symptoms tend to improve concurrently with obsessive-compulsive disorder (OCD) symptoms during cognitive behavioral therapy (CBT), despite depression not being the primary target of intervention. Studies examining the temporal or mediational relationships of OCD and depressive symptoms have indicated…
The background highlights the challenges faced by veterans with TRD, suicide risk, and PTSD symptoms, emphasizing the need for effective and durable treatment options. Objective: The primary objective is to assess the durability of deep transcranial magnetic stimulation in improving symptoms of…
It is normal for people to feel sad occasionally or have less enthusiasm for tasks that they once loved to do. However, when these feelings persist for an extended period, they may be a symptom of depression. Depression isn’t a defect of…
Major depressive disorder (MDD) stands as one of the most prevalent and incapacitating health conditions globally, and regrettably, numerous patients do not exhibit positive responses to traditional antidepressant medication or talk therapy approaches. Deep transcranial magnetic stimulation (Deep TMS) has emerged as…
